International Companies

Soaring demand for weight-loss drugs boost profits at Novo Nordisk

By Abigail Townsend

Date: Wednesday 06 Nov 2024

(Sharecast News) - Novo Nordisk posted quarterly numbers broadly in line with expectations on Wednesday, as demand for its weight-loss drugs continued to boom.
Total group sales rose 21%, or by 23% on a constant currency basis in the third quarter, to 71.2bn Danish krone (£7.9bn).

That was slightly lower...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page